Southeast Asia initiative to combat SARS-CoV-2 variants (SEACOVARIANTS) consortium

TL;DR

This project builds scientific capacity in Southeast Asia to quickly assess and respond to new SARS-CoV-2 variants and future emerging infections.

Contribution

The project establishes a multidisciplinary platform in Southeast Asia to rapidly evaluate SARS-CoV-2 variants and strengthen local pandemic response capabilities.

Findings

The SEACOVARIANTS consortium will enhance regional scientific capacity for real-time assessment of emerging SARS-CoV-2 variants.

The initiative will create a research network and train scientists in Southeast Asia to lead future outbreak responses.

The project demonstrates that low and middle-income countries can develop novel research platforms to address emerging infections.

Abstract

A strong and effective COVID-19 and future pandemic responses rely on global efforts to carry out surveillance of infections and emerging SARS-CoV-2 variants and to act accordingly in real time. Many countries in Southeast Asia lack capacity to determine the potential threat of new variants, or other emerging infections. Funded by Wellcome, the Southeast Asia initiative to combat SARS-CoV-2 variants (SEACOVARIANTS) consortium aims to develop and apply a multidisciplinary research platform in Southeast Asia (SEA) for rapid assessment of the biological significance of SARS-CoV-2 variants, thereby informing coordinated local, regional and global responses to the COVID-19 pandemic. Our proposal is delivered by the Vietnam and Thailand Wellcome Africa Asia Programmes, bringing together a multidisciplinary team in Indonesia, Thailand and Vietnam with partners in Singapore, the UK and the USA. Herein we outline five work packages to deliver strengthened regional scientific capacity that can be rapidly deployed for future outbreak responses.

Our project strengthens local scientific capacity in South East Asia (SEA) and therefore enables the rapid assessment of SARS-CoV-2 variants as they emerge within the region. While COVID-19 remains a global pandemic, future emerging infections caused by a novel virus is an inevitable event, with SEA being a global hot-spot for pathogen emergence. Consequently, the research capacity built, the scientists trained and the research network formed as part of this project will lay the foundation for future locally-led outbreak responses. Our project will demonstrate that novel research platforms can be set up in other low and middle income countries to address the unprecedented challenges presented by emerging infections.

Figures